Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry
Crossref DOI link: https://doi.org/10.1186/s13075-015-0776-1
Published Online: 2015-09-18
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Harrold, Leslie R.
Reed, George W.
Magner, Robert
Shewade, Ashwini
John, Ani
Greenberg, Jeffrey D.
Kremer, Joel M.